🔎 Trials Near Me

Home › Esophageal Adenocarcinoma › Minnesota › Minneapolis

Esophageal Adenocarcinoma clinical trials in Minneapolis, MN

6 studies for Esophageal Adenocarcinoma are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

RecruitingPhase 2/3
  • Abbott-Northwestern Hospital, Minneapolis
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi away
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

RecruitingPhase 3
  • Abbott-Northwestern Hospital, Minneapolis
  • Hennepin County Medical Center, Minneapolis
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi away
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05677490

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

RecruitingPhase 1
  • Normunity Investigational Site, Minneapolis
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07182149

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

RecruitingPhase 1/2
  • M Health Fairview University of Minnesota Medical Center, Minneapolis
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06330064

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

RecruitingPhase 1
  • Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT04389632

Esophageal Adenocarcinoma trials in other cities

Other studies in Minneapolis

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.